<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02676518</url>
  </required_header>
  <id_info>
    <org_study_id>057/2015</org_study_id>
    <nct_id>NCT02676518</nct_id>
  </id_info>
  <brief_title>AMH, Glucose Intolerance and Metabolic Syndrome in PCOS</brief_title>
  <official_title>Anti-MÃ¼llerian Hormone and Its Association With Glucose Intolerance and Metabolic Syndrome in Women With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Association between serum anti-Mullerian hormone (AMH) level and prevalence of glucose
      intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  To study the association between serum anti-Mullerian hormone (AMH) level and glucose
           intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS).

        -  Glucose intolerance is detected by 2-hours 75 gram oral glucose tolerance test (OGTT).

        -  Metabolic syndrome is diagnosed by using the Harmonized criteria; the presence of any 3
           of 5 following risk factors constitutes a diagnosis of metabolic syndrome.

             1. Elevated waist circumference (&gt; 80 cm in Asian women)

             2. Elevated triglycerides (&gt; 150 mg/dL)

             3. Reduced HDL-cholesterol (&lt; 50 mg/dL)

             4. Elevated blood pressure )systolic &gt; 130 and/or diastolic &gt; 85 mmHg)

             5. Elevated fasting glucose ( &gt; 100 mg/dL)

        -  Percentage of glucose intolerance and metabolic syndrome in PCOS women as well was any
           differences in parameters between PCOS patients with and without glucose intolerance and
           metabolic syndrome will be analysed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences between serum AMH level between PCOS women with and without glucose intolerance and metabolic syndrome</measure>
    <time_frame>6 months</time_frame>
    <description>Any differences between mean of serum AMH levels in PCOS with and without glucose intolerance and metabolic syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of glucose intolerance in PCOS women</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of glucose intolerance detected by 75 g OGTT in PCOS women</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of metabolic syndrome in PCOS women</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of metabolic syndrome defined by the Harmonized criteria in PCOS women</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>polycystic ovary syndrome women</arm_group_label>
    <description>PCOS women diagnosed by Rotterdam criteria visiting the Gynecologic Unit at King Chulalongkorn Memorial Hospital and meet the inclusion criteria and no exclusion criteria of the study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>serum</intervention_name>
    <description>Serum for serum anti-Mullerian hormone, 2-hour 75 gram oral glucose tolerance test and lipid profiles</description>
    <arm_group_label>polycystic ovary syndrome women</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  Serum anti-mullerian hormone level

        -  Blood test for 2-hours 75 gram glucose tolerance test

        -  Blood tests for total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Thai women with PCOS diagnosed by Rotterdam criteria 2003 who visit at Gynecological
        Department, King Chulalongkorn Memorial Hospital, Bangkok,Thailand
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCOS diagnosed by Rotterdam criteria 2003

        Exclusion Criteria:

          -  Pregnancy

          -  Previous any hormonal uses in the last 3 months

          -  Previous hypoglycemic drugs or insulin-sensitising agents use in the last 3 months

          -  Previous chemotherapy, ovarian surgery, pelvic irradiation

          -  Menopause
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dhirapong Charoenvidya, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wasamon Tunsuparp, MD</last_name>
    <phone>66850658502</phone>
    <email>wasamontun@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Porntip Sirayapiwat, MD, MSc</last_name>
    <phone>66818378923</phone>
    <email>p_siraya@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wasamon Tunsuparp, MD</last_name>
      <email>wasamontun@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Porntip Sirayapiwat, MD, MSc</last_name>
      <email>p_siraya@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Wasamon Tunsuparp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Porntip Sirayapiwat, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patchaya Boonchayaanant, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2016</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Porntip Sirayapiwat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>polycystic ovary syndrome</keyword>
  <keyword>Serum anti-Mullerian hormone</keyword>
  <keyword>glucose intolerance</keyword>
  <keyword>metabolic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>September 28, 2016</submitted>
    <returned>November 17, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

